IMNM SG&A Expense Growth

Immunome Inc · SG&A Expense Growth

IMNM logo

IMNM SG&A Expense Growth

Latest reported32.81%
IMNM FY SG&A Growth (YoY) (0.00% → 32.81%)
High-resolution chart · PNG

IMNM sg&a expense growth history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Immunome Inc SG&A Expense Growth — Annual fiscal periods
Period endingSG&A Expense Growth
32.8114%
67.6502%
44.2292%
22.8502%
132.3351%
213.1148%
76.097%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.